Suchergebnisse

In its upcoming report, Delta Air Lines (DAL) is predicted by Wall Street analysts to post quarterly earnings of $0.63 per share, reflecting an increase of 37% compared to the same period last

Shares of Ultragenyx Pharmaceutical RARE rose 5% after the company announced that the FDA has accepted its resubmitted biologics license application (BLA) seeking accelerated approval for AAV gene

U.S. non-farm payrolls increased a seasonally adjusted 178,000 in March, marking a sharp reversal from the 133,000 drop in February and better than the Dow Jones consensus estimate for 59,000, as

WeRide Inc. WRD and Grab GRAB have introduced Singapore’s first autonomous public ride service in a residential area through the Ai.R (Autonomously Intelligent Ride) platform in Punggol. The service

Stereotaxis STXS recently announced that the FDA granted 510(k) clearance for its Synchrony system, a next-generation platform aimed at modernizing interventional cath labs.

The Synchrony system is

In its upcoming report, FB Financial (FBK) is predicted by Wall Street analysts to post quarterly earnings of $1.15 per share, reflecting an increase of 35.3% compared to the same period last year

• Legence Corp.’s LGN shares rose 3.3% after it reported a fourth-quarter 2025 loss of 1 cent per share, narrower than the Zacks Consensus Estimate of a loss of 3 cents.
• Shares of NVIDIA Corporation

Americas Gold and Silver USAS reported an adjusted net loss of $35.2 million in 2025, wider than the year-ago adjusted loss of $33.7 million. Gains from higher net revenues were offset by planned

Ultragenyx Pharmaceutical RARE announced that the FDA has accepted its investigational new drug (IND) application for UX016, an investigational small-molecule prodrug of sialic acid, which is being

PVH Corporation PVH posted fourth-quarter fiscal 2025 results, wherein both revenues and earnings topped the Zacks Consensus Estimate. Both metrics also increased year over year. PVH ended 2025 on a